Potential new first-line treatment strategy for patients with BRAF V600E-mutant metastatic colorectal cancer

by VHIO

The BREAKWATER open-label, randomized phase 3 study was designed to evaluate first-line treatment with targeted therapies encorafenib and cetuximab plus chemotherapy compared to standard of care in pa...

Read more

A CNIO study identifies new genes that predispose an individual to pancreatic cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

It has been discovered that the probability of developing pancreatic cancer may increase when two specific genes in the complement system become mutated. These genes, called FCN1 and PLAT, could becom...

Read more

CNIO reinforces AI and clinical research to get advances reach patients sooner

by CNIO - Centro Nacional de Investigaciones Oncológicas

The CNIO, Spain's leading cancer research center, focuses its scientific, technological, and human resources on the major challenges currently faced by cancer research.

Read more

Investigadores del IBiS demuestran que el fármaco Ibudilast protege contra la pérdida de neuronas en ratones con Parkinson

by Instituto de Biomedicina de Sevilla - IBIS

La investigación publicada en la revista Journal of Neurochemistry, revela que el uso de un fármaco, el Ibudilast, logra frenar la pérdida de neuronas dopaminérgicas en modelo murino de Parkinson

Read more

Estudio de miRNAs y MSI2 como posibles dianas para la distrofia miotónica tipo 1

by IQS Institut Químic de Sarrià

El Dr. Daniel Fernández Remacha defendió su tesis doctoral en IQS, en la que ha establecido un nuevo enfoque para el tratamiento de la distrofia miotónica tipo 1, la más común en adultos, que se ...

Read more

Estudio del mecanismo de influencia de la diabetes en el deterioro cognitivo

by IQS Institut Químic de Sarrià

El Dr. Francesc Guix forma parte del proyecto DiaAD, un consorcio estatal que tiene como objetivo establecer la influencia de la diabetes tipo 2 en la inducción del deterioro cognitivo y desarrollo d...

Read more

Machine learning to identify the factors that may determine the age of onset of Huntington’s disease

by Universitat de Barcelona

A team from the Faculty of Medicine and Health Sciences and the Institute of Neurosciences at the University of Barcelona (UBneuro) has applied advanced artificial intelligence techniques to better un...

Read more

Investigando el rol del gen ACOX2 en la hepatitis aguda pediátrica

by Biodonostia

Como resultado, solo se encontraron mutaciones en este gen en un caso pediátrico y otro en adulto y, probablemente, no afectarían completamente la función del gen. Así, no parece que las mutacione...

Read more

The future of Clinical Trials

by GENESIS Biomed

Digital transformation and artificial intelligence are redefining the traditional model of clinical trials.

Read more

A study led by Vall d’Hebron identifies the first case of spontaneous genetic correction in a severe immunodeficiency linked to the Epstein–Barr virus

by Vall d’Hebron

The paper describes the case of a patient in whom, years after a bone marrow transplant, two immune cell lines corrected the original genetic defect.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream